Stevanato Group S.p.A. Azioni nom. o.N.
- BID
16.5
- ASK
16.8
- 2,968 Units2,910 Units
- 07/21, 19:27:10 PM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
20.00%
Market Cap
-
P/E Ratio
34.80
Dividend Yield
0.31 %
Earnings per Share
0.51 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 16.5 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 07:18:07 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 16.9 | 16.5 |
| PREV. DAY'S PRICE | 16.8 | (07/20) |
| CHANGE DAY BEFORE | -0.30 | -1.79 % |
| 52 WEEK HIGH / LOW | 23.6 (07/25) | 11.2 (03/27) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.55 | 0.43 | 0.51 | 0.60 | 0.72 |
DIVIDENDS PER SHARE | 0.05 | 0.06 | 0.06 | 0.06 | 0.07 |
DIVIDEND YIELD IN % | 0.21 % | 0.28 % | 0.31 % | - | - |
DIVIDEND GROWTH IN % | -3.61 % | 7.45 % | -3.19 % | - | - |
PRICE - EARNINGS RATIO | 45.93 | 46.37 | 34.80 | 27.91 | 23.27 |
PRICE - BOOK RATIO | 5.79 | 4.09 | 3.15 | - | - |
PRICE - SALES RATIO | 6.16 | 4.95 | 4.10 | - | - |
PRICE - CASH FLOW RATIO | 63.57 | 35.06 | 17.01 | - | - |
Master Data
| WKN | A3CUMB |
| ISIN | IT0005452658 |
| SYMBOL | 87N |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | STEVANATO GROUP SPA O.N. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.33 % | 11.26 % | 24.44 % | 3.07 % | -20.00 % | -43.24 % | 0.24 % | -2.89 % |
| HIGH | 17.60 | 17.60 | 17.60 | 17.60 | 23.60 | 32.40 | 32.40 | 18.70 |
| LOW | 16.30 | 14.50 | 12.80 | 11.20 | 11.20 | 11.20 | 11.20 | 11.20 |
Dividende
pro Aktie
Company profile
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.